Active

NUPHAR TECH

Switched

BE0700488270

Rechtspersoon Private limited company 1 establishment

Jan Van Looylaan(Kok) 5, 8670 Koksijde Speur- en ontwikkelingswerk op biotechnologisch gebied

Active for

8 year, 1 month

Financials

Financial year 2025

Worth noting

  • More debts than assets in the latest financial year.
  • A loss two years in a row.
  • Little cash and receivables against the short-term debts.

Gross margin

€ -53,085

▼ 314% vs 2024

Profit

Caution

€ -12,121

▲ 11% vs 2024

Debts

High

€ 236,783

▲ 5% vs 2024

NUPHAR TECH from Koksijde, company number BE0700488270, closed financial year 2025 with a result of € -12,121 after tax. For that financial year NUPHAR TECH recorded a gross margin of € -53,085 and equity of € -216,475. Compared with financial year 2024, the result moved from € -13,561 to € -12,121. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 1, 2026.

What happened at NUPHAR TECH?

What happened at NUPHAR TECH in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: loss of € 12,121. Source: NBB ↗
  • New establishment in Koksijde. KBO
  • Start of the company according to the CBE. KBO

In short

From € 75,121 loss in 2021 to € 12,121 loss in 2025.

Best year ever: 2023, with € 1,077 profit.

A new publication or filing at NUPHAR TECH? We notify you, reason included.

Follow NUPHAR TECH

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

Kris Baes
NUPHAR TECH
+2

Behind NUPHAR TECH is Kris Baes. Kris Baes is also behind XMED, Nascendi, HECAM, BAES-BLANCKAERT and UNIPHARM.

See the full network in the app

Directors

According to the 2025 annual accounts

Kris Baes

Director

Also active at: XMED, Nascendi, HECAM +2 more

Establishments

Establishment units

Physical locations of this company

Registered office

Jan Van Looylaan(Kok) 5

8670 Koksijde

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number
0700.488.270
VAT number
BE 0700.488.270
Registered office
Jan Van Looylaan(Kok) 5, 8670 Koksijde
Names & denominations
NUPHAR TECH
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
30 July 2018
Peppol
Active · Active since 7 Jul 2025
Activities · NACE

Speur- en ontwikkelingswerk op biotechnologisch gebied

Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied

Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied

Frequently asked questions

What is the enterprise number of NUPHAR TECH?
The enterprise number of NUPHAR TECH is BE0700488270.
What is the address of NUPHAR TECH?
The registered office of NUPHAR TECH is located at Jan Van Looylaan(Kok) 5, 8670 Koksijde.
When was NUPHAR TECH founded?
NUPHAR TECH was founded on 30 July 2018.
What is the main activity of NUPHAR TECH?
The main activity of NUPHAR TECH is "Speur- en ontwikkelingswerk op biotechnologisch gebied" (NACE code 72101).
Does NUPHAR TECH have a website?
No website is currently known for NUPHAR TECH.
How much profit did NUPHAR TECH make in 2025?
NUPHAR TECH recorded a loss after taxes of € 12,121 in financial year 2025.
What is the revenue of NUPHAR TECH?
As a small company, NUPHAR TECH is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € -53,085.
Where can I find the annual accounts of NUPHAR TECH?
NUPHAR TECH files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of NUPHAR TECH?
According to the 2025 annual accounts, the directors of NUPHAR TECH are: Kris Baes.
Who owns NUPHAR TECH?
Behind NUPHAR TECH is Kris Baes. Kris Baes is also behind XMED, Nascendi, HECAM, BAES-BLANCKAERT and UNIPHARM.